Epidemiological studies have also reported associations between inflammatory markers and type 2 diabetes through elevated plasma concentration of inflammatory mediators, such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6)30–32. Here, IL6 is linked to type 2 diabetes mellitus.